Howard Wolinsky’s continuing patient journey

To quote Howard himself, “Not much on PC, but FYI.” But on the other hand, it is very much about the sometimes challenging aspects of “being a patient” — prostate cancer included. … READ MORE …

Howard Wolinsky has a new problem …

… and it’s one that is not exactly uncommon for older men (with or without prostate cancer). … To get the scoop, just click here. … READ MORE …

A potential downside to metformin in the treatment of men with diabetes

There have been suggestions for some time (but no confirmation yet from large scale clinical trials) that treatment with the antidiabetic agent metformin may be beneficial in the management of at least some forms of prostate cancer. However, … READ MORE …

Can metformin extend survival of prostate cancer patients with (or without) diabetes?

A retrospective analysis of data from  > 3,800 Canadian men has suggested that diabetic men who also had prostate cancer and were being treated with a commonly used, generic drug called metformin have a reduced risk for death from prostate cancer. … READ MORE …

Radiation therapy for localized prostate cancer in men with diabetes mellitus

A new paper recently published on line in Urology (“the Gold Journal”) suggests that men with diabetes who are treated with curative intent for localized prostate cancer using external beam radiation therapy may experience higher than normal risk for late genitourinary complications and adverse effects. … READ MORE …

The impact of ADT on diabetics who are also diagnosed with prostate cancer

It has long been understood that treatment of prostate cancer with androgen deprivation therapy (ADT) can both increase the risk for diabetes among non-diabetic patients and can decrease sensitivity to insulin among men with diabetes. What has been missing, however, are good data about how ADT affects diabetes control among men with diabetes. … READ MORE …

Of genetics, diabetes, and prostate cancer risk

We know from a number of older, epidemiologic studies that there seems to be an inverse association between diabetes status and prostate cancer risk. In other words, people with diabetes seem to be less likely to be diagnosed with prostate cancer. … READ MORE …